Hypoparathyroidism Treatment Market Trends
- Increasing incidence of hypoparathyroidism is a significant driving factor. The prevalence of hypoparathyroidism is an estimated 37 per 100 000 person-years in the U.S. Additionally, it is estimated that approximately 7.6% of all thyroid related surgeries result in hypoparathyroidism.
- Thus, as the number of cases increases, the demand for treatment also rises, thereby driving the market growth.
- Further, growing awareness about parathyroid disorders, their symptoms, and potential complications has led to an increased number of patients seeking medical advice and treatment. This awareness results in a higher number of diagnosed cases and, consequently, a greater demand for hypoparathyroidism treatments.
However, the high cost of treatment can impose a significant financial burden on patients and their families. Consequently, due to financial constraints, some individuals delay seeking medical attention or avoid necessary tests and treatments for hypoparathyroidism, thereby impeding market growth to some extent.